Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform.

• Κύριοι συγγραφείς: Jacob T Bush (Συγγραφέας), Monique Wasunna (Συγγραφέας), Fabiana Alves (Συγγραφέας), Jorge Alvar (Συγγραφέας), Piero L Olliaro (Συγγραφέας), Michael Otieno (Συγγραφέας), Carol Hopkins Sibley (Συγγραφέας), Nathalie Strub Wourgaft (Συγγραφέας), Philippe J Guerin (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Public Library of Science (PLoS), 2017-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

There are an estimated 200,000 to 400,000 cases of visceral leishmaniasis (VL) annually. A variety of factors are taken into account when considering the best therapeutic options to cure a patient and reduce the risk of resistance, including geographical area, malnourishment and HIV coinfection. Poo...